Rewiring Healthcare: The AI Push to Shatter Medical Data Silos

BOSTON, MA – November 10, 2026 – For all the billions of dollars poured into digitizing modern medicine over the past two decades, the patient experience remains remarkably, frustratingly analog. We digitized the records, but we forgot to connect the plumbing. Patients still recite their medical histories from memory at every specialist visit, while clinicians spend precious administrative hours hunting down fragmented files across disconnected networks.

Now, a new wave of infrastructure is attempting to solve the interoperability crisis that legacy systems left behind. Leading this charge is Zus Health, an AI-native healthcare data platform that today announced a $33 million Series B financing round led by Drive Capital. With participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, and returning heavyweights like Andreessen Horowitz (a16z) and F-Prime, the Boston-based startup has pushed its total capital raised past the $100 million mark.

The funding arrives at a critical inflection point for healthcare technology. The industry is currently transitioning from simply moving data between walled gardens to actually synthesizing it into actionable clinical insights. By combining nationwide data aggregation with generative artificial intelligence, this latest capital injection highlights a broader market realization: the future of healthcare competition will be won not by who hoards the most data, but by who can make it the most useful at the point of care.

The EHR Disillusionment and a Founder's Second Act

To understand the current state of medical data, one must look at the regulatory landscape that created it. Federal mandates successfully pushed hospitals to adopt Electronic Health Records (EHRs), but they inadvertently spawned a fractured ecosystem of proprietary systems.

Jonathan Bush, who founded Zus Health in 2021, knows this architecture intimately. As the co-founder and former CEO of athenahealth, he spent years building one of the ambulatory EHR giants that defined the first wave of healthcare digitization. Now, his second act is focused on breaking open the very silos that era created.

"The story of electronic medical records doesn't end with the silos we have today," said Jonathan Bush, founder and CEO of Zus Health. "We've spent decades digitizing healthcare, but the information still doesn't move with the patient. We're building a networked medical record that changes that — connecting information across the healthcare system and making it available to the people and applications that need it. And now, with AI, we have an extraordinary opportunity to build workflows that actually make delivering care easier, faster, and more effective."

The firm's core offering, the Zus Aggregated Profile (ZAP), acts as an interoperability overlay. It pulls fragmented clinical information from various external networks, labs, and pharmacies, merging it with a care team's first-party data into a unified, longitudinal patient record. Utilizing the HL7 FHIR Release 4 (R4) standard, the platform normalizes terminology and deduplicates records, covering over 270 million patients across more than 70,000 provider sites. It is a fundamental shift from treating patient data as a proprietary asset to treating it as a shared, continuously updated utility.

The TEFCA Stakes: Racing for the National Network

The technological hurdles of interoperability are only half the battle; the other half is regulatory. The healthcare interoperability market, valued at approximately $5.1 billion today, is projected to surge past $10 billion by the early 2030s. A massive driver of this growth is the Trusted Exchange Framework and Common Agreement (TEFCA), a federal initiative that officially went live in December 2023 to establish a universal floor for interoperability across the country.

Under TEFCA, organizations must connect through a designated Qualified Health Information Network (QHIN). In August 2026, Zus announced its candidacy to become a QHIN, entering a grueling, roughly 12-month gauntlet overseen by the Office of the National Coordinator for Health IT (ONC) and The Sequoia Project. This process requires candidate networks to pass rigorous technical conformance and non-production partner testing.

Securing this designation is a high-stakes race for digital health platforms. The landscape is already fraught with friction. Competitors in the health data aggregation space, such as Particle Health and Health Gorilla, have recently found themselves entangled in high-profile legal and operational disputes with legacy EHR vendors like Epic over data access, appropriate use cases, and monetization. These skirmishes underscore the immense sensitivity and trust required to broker medical records.

By pursuing QHIN status while maintaining strict HITRUST certification, the company is positioning itself as a "compliant by design" alternative, aiming to bypass the friction of point-to-point integrations and offer customers direct, trusted access to the national health data backbone.

From Data Retrieval to Action: The Generative AI Catalyst

Moving a PDF or a raw XML file from one hospital to another is no longer the gold standard of interoperability. If a physician receives a 200-page consolidated clinical document (C-CDA) right before a 15-minute consultation, the data is accessible, but it is entirely unactionable. This is where the integration of artificial intelligence is fundamentally rewriting the value chain.

The Series B funding will heavily support the advancement of AI-powered clinical intelligence. Rather than just acting as a data pipeline, modern platforms must act as synthesizers. Zus’s AI-native clinical platform utilizes Generated Patient Summaries (GPS) to parse complex, unstructured medical histories and transform them into concise, trusted insights.

The scale of this synthesis is already substantial. In August alone, the nationwide network supported more than 110 million networked transactions. More importantly, its AI engine generated 39 million evidence citations year-to-date. By grounding AI summaries in specific, traceable evidence citations, the platform directly addresses the medical community's lingering fears regarding AI hallucinations and clinical liability.

"We believe healthcare is entering a new era in which AI can fundamentally change how care is delivered, but that transformation depends on having reliable, connected patient information," said Molly Bonakdarpour, General Partner at Drive Capital. "Zus has built the foundation to address that challenge at scale. Its combination of technology, market opportunity, and leadership gives us conviction in the company's ability to help shape the next generation of healthcare."

The Ripple Effect on the Healthcare Value Chain

As healthcare organizations face mounting pressure to transition toward value-based care, the demand for connected patient information has never been higher. Providers are financially incentivized to improve patient outcomes and manage chronic conditions proactively, a feat that is statistically impossible if care teams are operating with blind spots in a patient's medical history.

The ripple effects of this $33 million investment will be felt across multiple layers of the healthcare value chain. For digital health startups and precision medicine innovators, having a shared foundation of connected patient information means they can deploy new applications without having to rebuild underlying data infrastructure from scratch. For payers and risk-bearing entities, automated quality gap closures and risk adjustments become significantly more accurate when driven by a continuously updated, longitudinal record.

Ultimately, the success of this next generation of connected healthcare will rely on a delicate balance. Innovators must navigate the stringent regulatory frameworks of TEFCA, maintain the absolute trust of providers and patients, and leverage generative AI not as a replacement for clinical judgment, but as a scalpel to cut through administrative noise. As the industry moves further away from the fragmented legacy of early EHRs, the mandate is clear: healthcare information must finally begin to move at the speed of care.